Cargando…

Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity

Background: This study examines the relationship between the presence of crystals in the synovial fluid of patients with psoriatic arthritis (PsA) and disease activity. Methods: The synovial fluid of 156 PsA patients was analyzed and compared to 50 patients with gonarthrosis (GoA). The Leica DM4500P...

Descripción completa

Detalles Bibliográficos
Autores principales: Geneva-Popova, Mariela, Popova-Belova, Stanislava, Popova, Velicka, Stoilov, Nikolay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140193/
https://www.ncbi.nlm.nih.gov/pubmed/35626414
http://dx.doi.org/10.3390/diagnostics12051260
_version_ 1784715039249268736
author Geneva-Popova, Mariela
Popova-Belova, Stanislava
Popova, Velicka
Stoilov, Nikolay
author_facet Geneva-Popova, Mariela
Popova-Belova, Stanislava
Popova, Velicka
Stoilov, Nikolay
author_sort Geneva-Popova, Mariela
collection PubMed
description Background: This study examines the relationship between the presence of crystals in the synovial fluid of patients with psoriatic arthritis (PsA) and disease activity. Methods: The synovial fluid of 156 PsA patients was analyzed and compared to 50 patients with gonarthrosis (GoA). The Leica DM4500P polarization microscope was used for crystal detection. Results: The presence of crystals was observed in 23.71% of PsA patients and none of the GoA patients, p < 0.001. Monosodium urate crystals (67.58%) and calcium pyrophosphate crystals (21.62%) were prevalent. The presence of crystals in the synovial fluid of PsA patients was associated with high disease activity according to the Composite Psoriatic Disease Activity Index (OR = 18.75, 95%; CI: 7.13 to 49.25) and the Disease Activity for Psoriatic Arthritis (OR = 15.96, 95%; CI: 5.76 to 44.23), with severe disability according to the Health Assessment Questionnaire Disability Index (OR = 13.60, 95%; CI: 5.09 to 36.31), and with severe pain on the Visual Analog Scale (OR = 157.25, 95%; CI: 39.50 to 625.94). Conclusion: Our results suggest that synovial fluid examination should be included in the treatment pathway for PsA patients with active disease, to aid in determining whether urate-lowering therapy is required.
format Online
Article
Text
id pubmed-9140193
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91401932022-05-28 Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity Geneva-Popova, Mariela Popova-Belova, Stanislava Popova, Velicka Stoilov, Nikolay Diagnostics (Basel) Article Background: This study examines the relationship between the presence of crystals in the synovial fluid of patients with psoriatic arthritis (PsA) and disease activity. Methods: The synovial fluid of 156 PsA patients was analyzed and compared to 50 patients with gonarthrosis (GoA). The Leica DM4500P polarization microscope was used for crystal detection. Results: The presence of crystals was observed in 23.71% of PsA patients and none of the GoA patients, p < 0.001. Monosodium urate crystals (67.58%) and calcium pyrophosphate crystals (21.62%) were prevalent. The presence of crystals in the synovial fluid of PsA patients was associated with high disease activity according to the Composite Psoriatic Disease Activity Index (OR = 18.75, 95%; CI: 7.13 to 49.25) and the Disease Activity for Psoriatic Arthritis (OR = 15.96, 95%; CI: 5.76 to 44.23), with severe disability according to the Health Assessment Questionnaire Disability Index (OR = 13.60, 95%; CI: 5.09 to 36.31), and with severe pain on the Visual Analog Scale (OR = 157.25, 95%; CI: 39.50 to 625.94). Conclusion: Our results suggest that synovial fluid examination should be included in the treatment pathway for PsA patients with active disease, to aid in determining whether urate-lowering therapy is required. MDPI 2022-05-18 /pmc/articles/PMC9140193/ /pubmed/35626414 http://dx.doi.org/10.3390/diagnostics12051260 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Geneva-Popova, Mariela
Popova-Belova, Stanislava
Popova, Velicka
Stoilov, Nikolay
Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity
title Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity
title_full Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity
title_fullStr Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity
title_full_unstemmed Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity
title_short Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity
title_sort assessment of crystals in the synovial fluid of psoriatic arthritis patients in relation to disease activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140193/
https://www.ncbi.nlm.nih.gov/pubmed/35626414
http://dx.doi.org/10.3390/diagnostics12051260
work_keys_str_mv AT genevapopovamariela assessmentofcrystalsinthesynovialfluidofpsoriaticarthritispatientsinrelationtodiseaseactivity
AT popovabelovastanislava assessmentofcrystalsinthesynovialfluidofpsoriaticarthritispatientsinrelationtodiseaseactivity
AT popovavelicka assessmentofcrystalsinthesynovialfluidofpsoriaticarthritispatientsinrelationtodiseaseactivity
AT stoilovnikolay assessmentofcrystalsinthesynovialfluidofpsoriaticarthritispatientsinrelationtodiseaseactivity